Activated ras oncogenes in human thyroid cancers
- PMID: 3293774
Activated ras oncogenes in human thyroid cancers
Abstract
Human thyroid epithelial (follicular) cells give rise to two malignant tumors--"follicular" carcinomas, which metastasize almost exclusively via the bloodstream, and "papillary" carcinomas, which metastasize predominantly via lymphatics (Williams, E. D. In: W. Duncan (ed.), Recent Results in Cancer Research: Thyroid Cancer, pp. 47-55. Berlin: Springer-Verlag, 1980). We have investigated whether this contrast in biological behavior might be associated with different patterns of oncogene activation. DNA transfection analysis of five follicular and ten papillary cancers indeed showed a statistically significant difference in the pattern of genes responsible, activated ras oncogenes being found in 80% of follicular tumors but only 20% of papillary tumors. In addition, in follicular cancers we have found activation of all three ras oncogenes (H-ras, K-ras, and N-ras), the first time that this has been demonstrated in a primary human tumor type (as opposed to cell lines). We suggest therefore that ras activation may be an important determinant of metastatic capability in these epithelial cancers.
Similar articles
-
Detection of activated ras oncogenes in human thyroid carcinomas.Oncogene. 1988 Apr;2(4):403-6. Oncogene. 1988. PMID: 3283656
-
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.J Clin Oncol. 2003 Sep 1;21(17):3226-35. doi: 10.1200/JCO.2003.10.130. J Clin Oncol. 2003. PMID: 12947056
-
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.Oncogene. 2006 Aug 31;25(39):5467-74. doi: 10.1038/sj.onc.1209527. Epub 2006 Jun 19. Oncogene. 2006. PMID: 16785999
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
-
[Activated oncogenes in human tumors].Bull Cancer. 1987;74(6):607-21. Bull Cancer. 1987. PMID: 3325106 Review. French.
Cited by
-
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction.Cell Genom. 2023 Sep 14;3(10):100409. doi: 10.1016/j.xgen.2023.100409. eCollection 2023 Oct 11. Cell Genom. 2023. PMID: 37868034 Free PMC article.
-
Progress in Thyroid Cancer Genomics: A 40-Year Journey.Thyroid. 2023 Nov;33(11):1271-1286. doi: 10.1089/thy.2023.0045. Epub 2023 Sep 4. Thyroid. 2023. PMID: 37668657 Review.
-
Metabolomics-A Tool to Find Metabolism of Endocrine Cancer.Metabolites. 2022 Nov 21;12(11):1154. doi: 10.3390/metabo12111154. Metabolites. 2022. PMID: 36422294 Free PMC article. Review.
-
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.Cancer Cell Int. 2022 Aug 22;22(1):263. doi: 10.1186/s12935-022-02680-1. Cancer Cell Int. 2022. PMID: 35996174 Free PMC article.
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous